Samsung and Biogen Idec (BIIB) Enter Joint Venture to Develop, Manufacture and Market Biosimilars
Go back to Samsung and Biogen Idec (BIIB) Enter Joint Venture to Develop, Manufacture and Market Biosimilars| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.78 +2.43 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.76 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 722,318 | |||||
